Low Cost Nanowire Diagnostic Platform

该项目由南安普顿大学、夏普欧洲实验室、牛津仪器等离子技术和适体体解决方案合作完成。该项目将开发一种原型设备，用于诊断和管理呼吸系统疾病，如哮喘和慢性阻塞性肺病。该设备将测量患者血液中临床相关生物标志物的数量，从而实现更快的评估和更及时的治疗。这将大大降低患者需要住院的风险，从而大大提高他们的生活质量。我们项目中使用的方法也适用于其他疾病，因此从长远来看，这项技术有可能为一系列疾病提供廉价的家庭检测试剂盒。因此，该项目旨在为向医疗保健系统过渡提供技术手段，在该系统中，对复杂疾病的定期筛查可以预防和早期干预。

The project is a collaboration between the University of Southampton, Sharp Laboratories Europe, Oxford Instruments Plasma Technology and Aptamer Solutions. The project will develop a prototype device for the diagnosis and management of respiratory diseases, such as asthma and Chronic Obstructive Pulmonary Disease. The device will measure the amounts of clinically relevant biomarkers in a drop of patient blood and enable faster assessment and more timely treatment. This will significantly reduce the risk that the patient needs to be hospitalised, thus greatly improving their quality of life. The approach used in our project is also applicable to other diseases, so in the longer term the technology has the potential to provide cheap home testing kits for a range of diseases. The project therefore aims to provide the technological means for a transition to a healthcare system in which regular screening for complex diseases enables prevention and early intervention.